This is a milestone we can all be proud of!
For the first time, JMP has received a direct payment from a Chinese customer, Xiamen Amoytop Biotech Co., Ltd. This successful transaction is a testament to the hard work and collaboration between our China sales team and provides a clear roadmap for how we can streamline the sales process and close deals faster in the future.
This achievement also marks a significant step forward in our efforts to optimize the sales cycle and enhance the customer experience in China. It provides valuable insights into what works and what we can do to make future transactions even smoother.
Why this matters
This isn't just about one successful payment. This transaction is a blueprint for how we can all work together to accelerate sales in the Chinese market.
The core message is clear: Sales teams in China will be briefed in advance on all potential payment issues and have ready-to-use onboarding and payment documents, enabling faster closures. “We learned that being upfront about payment terms, including timelines and payment methods, is crucial,” Senior Associate Inside Sales Account Representative Amanda Liu said. “By setting these expectations early, we can prevent misunderstandings and delays.”
A suite of templates and checklists has been created that simplifies communication with customers. “Using these resources will help us speak the same language and keep the process moving,” Liu said. “By clarifying payment terms and using standardized documents from the start, we can significantly reduce the time it takes to close a deal and lower the costs associated with customer acquisition.”
“This successful direct payment is a fantastic example of what's possible when local expertise is combined with streamlined processes,” Liu continued. “By using the insights from this experience, we can make the sales process more efficient and effective for everyone involved.”
For further details on this transaction and the new process, you can reach out to Amanda Liu (@AmandaLiu).